Previous research has demonstrated that higher RRM1 expression is discovered to associated with shorter overall survival in non‐small cell lung cancer (NSCLC),24 non‐muscle‐invasive bladder cancer (NMIBC)25 and multiple myeloma patients.26 This evidence concerns the gene RRM1 and lung cancer.